| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Age-dependent insulin resistance in male mice with null deletion of the carcinoembryonic antigen-related cell adhesion molecule 2 gene
|
Ghanem, Simona S.
|
|
2017
|
60 |
9 |
p. 1751-1760
|
artikel
|
| 2 |
A new perspective on metformin therapy in type 1 diabetes
|
Livingstone, Rachel
|
|
2017
|
60 |
9 |
p. 1594-1600
|
artikel
|
| 3 |
Autoantibody binding in liquid phase to IL-2 in human sera is not type 1 diabetes specific
|
Marzinotto, Ilaria
|
|
2017
|
60 |
9 |
p. 1834-1835
|
artikel
|
| 4 |
Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study
|
But, Anna
|
|
2017
|
60 |
9 |
p. 1691-1703
|
artikel
|
| 5 |
Complement C5a induces mesenchymal stem cell apoptosis during the progression of chronic diabetic complications
|
Zhu, Ming
|
|
2017
|
60 |
9 |
p. 1822-1833
|
artikel
|
| 6 |
Diabetic ketoacidosis and diabetes associated with antipsychotic exposure among a previously diabetes-naive population with schizophrenia: a nationwide nested case–control study
|
Polcwiartek, Christoffer
|
|
2017
|
60 |
9 |
p. 1678-1690
|
artikel
|
| 7 |
Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in mice
|
Ida, Shogo
|
|
2017
|
60 |
9 |
p. 1761-1769
|
artikel
|
| 8 |
Early metabolic markers identify potential targets for the prevention of type 2 diabetes
|
Peddinti, Gopal
|
|
2017
|
60 |
9 |
p. 1740-1750
|
artikel
|
| 9 |
Genetic risk scores in the prediction of plasma glucose, impaired insulin secretion, insulin resistance and incident type 2 diabetes in the METSIM study
|
Stančáková, Alena
|
|
2017
|
60 |
9 |
p. 1722-1730
|
artikel
|
| 10 |
High glucose increases the formation and pro-oxidative activity of endothelial microparticles
|
Burger, Dylan
|
|
2017
|
60 |
9 |
p. 1791-1800
|
artikel
|
| 11 |
Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes
|
Griffin, Simon J.
|
|
2017
|
60 |
9 |
p. 1620-1629
|
artikel
|
| 12 |
Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study
|
Murphy, Helen R.
|
|
2017
|
60 |
9 |
p. 1668-1677
|
artikel
|
| 13 |
Metformin and ageing: improving ageing outcomes beyond glycaemic control
|
Valencia, Willy Marcos
|
|
2017
|
60 |
9 |
p. 1630-1638
|
artikel
|
| 14 |
Metformin: clinical use in type 2 diabetes
|
Sanchez-Rangel, Elizabeth
|
|
2017
|
60 |
9 |
p. 1586-1593
|
artikel
|
| 15 |
Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
|
Aroda, Vanita R.
|
|
2017
|
60 |
9 |
p. 1601-1611
|
artikel
|
| 16 |
Metformin: historical overview
|
Bailey, Clifford J.
|
|
2017
|
60 |
9 |
p. 1566-1576
|
artikel
|
| 17 |
Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome
|
Sam, Susan
|
|
2017
|
60 |
9 |
p. 1656-1661
|
artikel
|
| 18 |
Metformin use in pregnancy: promises and uncertainties
|
Lindsay, Robert S.
|
|
2017
|
60 |
9 |
p. 1612-1619
|
artikel
|
| 19 |
One-hour and two-hour postload plasma glucose concentrations are comparable predictors of type 2 diabetes mellitus in Southwestern Native Americans
|
Paddock, Ethan
|
|
2017
|
60 |
9 |
p. 1704-1711
|
artikel
|
| 20 |
Repurposing metformin for the prevention of cancer and cancer recurrence
|
Heckman-Stoddard, Brandy M.
|
|
2017
|
60 |
9 |
p. 1639-1647
|
artikel
|
| 21 |
Retinal vascular geometry and 6 year incidence and progression of diabetic retinopathy
|
Cheung, Carol Yim-lui
|
|
2017
|
60 |
9 |
p. 1770-1781
|
artikel
|
| 22 |
The effects of metformin on gut microbiota and the immune system as research frontiers
|
Pollak, Michael
|
|
2017
|
60 |
9 |
p. 1662-1667
|
artikel
|
| 23 |
The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype
|
Vinué, Ángela
|
|
2017
|
60 |
9 |
p. 1801-1812
|
artikel
|
| 24 |
The kynurenine:tryptophan ratio as a predictor of incident type 2 diabetes mellitus in individuals with coronary artery disease
|
Rebnord, Eirik W.
|
|
2017
|
60 |
9 |
p. 1712-1721
|
artikel
|
| 25 |
The mechanisms of action of metformin
|
Rena, Graham
|
|
2017
|
60 |
9 |
p. 1577-1585
|
artikel
|
| 26 |
The pharmacogenetics of metformin
|
Florez, Jose C.
|
|
2017
|
60 |
9 |
p. 1648-1655
|
artikel
|
| 27 |
The role of somatostatin in GLP-1-induced inhibition of glucagon secretion in mice
|
Ørgaard, Anne
|
|
2017
|
60 |
9 |
p. 1731-1739
|
artikel
|
| 28 |
The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes
|
Bus, Pascal
|
|
2017
|
60 |
9 |
p. 1813-1821
|
artikel
|
| 29 |
Up front
|
|
|
2017
|
60 |
9 |
p. 1559-1560
|
artikel
|
| 30 |
Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes
|
Panduru, Nicolae M.
|
|
2017
|
60 |
9 |
p. 1782-1790
|
artikel
|
| 31 |
60 years of metformin use: a glance at the past and a look to the future
|
Marshall, Sally M.
|
|
2017
|
60 |
9 |
p. 1561-1565
|
artikel
|
Tijdschrift beschrijving